Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

This publication has 26 references indexed in Scilit:

• Statistical Issues in Analysis of Diagnostic Imaging Experiments with Multiple Observations per Patient
  Radiology, 2001
• Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
  New England Journal of Medicine, 2000
• Positron emission tomography with ¹⁸fluorine‐labelled deoxyglucose: utility in localized and advanced prostate cancer
  BJU International, 1999
• COMPARISON OF HELICAL COMPUTERIZED TOMOGRAPHY, POSITRON EMISSION TOMOGRAPHY AND MONOCLONAL ANTIBODY SCANS FOR EVALUATION OF LYMPH NODE METASTASES IN PATIENTS WITH PROSTATE SPECIFIC ANTIGEN RELAPSE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER
  Journal of Urology, 1999
• Clinical Trials in Relapsed Prostate Cancer: Defining the Target
  JNCI Journal of the National Cancer Institute, 1996
• Detection of bony metastases of androgen-independent prostate cancer by PET-FDG
  Nuclear Medicine and Biology, 1996
• How Much Can We Rely on the Level of Prostate-Specific Antigen as an End Point for Evaluation of Clinical Trials? A Word of Caution!
  JNCI Journal of the National Cancer Institute, 1996
• Metabolic Imaging of Untreated Prostate Cancer by Positron Emission Tomography with sup 18 Fluorine-Labeled Deoxyglucose
  Journal of Urology, 1996
• Application of the McNemar test to non‐independent matched pair data
  Statistics in Medicine, 1991
• Note on the sampling error of the difference between correlated proportions or percentages
  Psychometrika, 1947